These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 19946337

  • 1. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
    Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy N, Noguera R, Laureys G, Schramm A, Eggert A, Westermann F, Speleman F, Vandesompele J.
    Oncogene; 2010 Mar 04; 29(9):1394-404. PubMed ID: 19946337
    [Abstract] [Full Text] [Related]

  • 2. MYCN regulates oncogenic MicroRNAs in neuroblastoma.
    Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B.
    Int J Cancer; 2008 Feb 01; 122(3):699-704. PubMed ID: 17943719
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C.
    Differentiation; 2011 Jan 01; 81(1):25-34. PubMed ID: 20980091
    [Abstract] [Full Text] [Related]

  • 4. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
    Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, Milosavljevic A, Kim ES, Gunaratne PH.
    Cancer Res; 2011 Jun 01; 71(11):3841-51. PubMed ID: 21498633
    [Abstract] [Full Text] [Related]

  • 5. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M.
    Genome Biol; 2008 Oct 13; 9(10):R150. PubMed ID: 18851746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F.
    Cancer Res; 2010 May 01; 70(9):3791-802. PubMed ID: 20424123
    [Abstract] [Full Text] [Related]

  • 8. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
    Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S.
    Cancer Lett; 2015 Feb 01; 357(1):412-418. PubMed ID: 25475555
    [Abstract] [Full Text] [Related]

  • 9. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
    Haug BH, Hald ØH, Utnes P, Roth SA, Løkke C, Flægstad T, Einvik C.
    Anticancer Res; 2015 May 01; 35(5):2521-30. PubMed ID: 25964525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
    Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C.
    Carcinogenesis; 2011 Jul 01; 32(7):1005-12. PubMed ID: 21572098
    [Abstract] [Full Text] [Related]

  • 16. MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma.
    Charlet J, Szemes M, Malik KT, Brown KW.
    Mol Carcinog; 2014 May 01; 53(5):413-20. PubMed ID: 23280764
    [Abstract] [Full Text] [Related]

  • 17. Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells.
    Chayka O, D'Acunto CW, Middleton O, Arab M, Sala A.
    J Biol Chem; 2015 Jan 23; 290(4):2198-212. PubMed ID: 25477524
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.